The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line

Nature

Volumn 500, Issue 7461, 2013, Pages 207-211

  Adey, Andrew ^a   Burton, Joshua N ^a   Kitzman, Jacob O ^a   Hiatt, Joseph B ^a   Lewis, Alexandra P ^a   Martin, Beth K ^a   Qiu, Ruolan ^a   Lee, Choli ^a   Shendure, Jay ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CHROMOSOME; CYTOLOGY; DATA SET; GENETIC ANALYSIS; GENOME; GENOTYPE; HETEROZYGOSITY; MEDICINE; MUTATION; RESEARCH WORK;

ANEUPLOIDY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; COPY NUMBER VARIATION; EPIGENETICS; FEMALE; GENE DOSAGE; GENOME; HAPLOTYPE; HELA CELL; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 18; INDEL MUTATION; KARYOTYPE; PRIORITY JOURNAL; RNA SEQUENCE;

ANEUPLOIDY; DNA COPY NUMBER VARIATIONS; EPIGENOMICS; FEMALE; GENES, MYC; GENOME, HUMAN; HAPLOTYPES; HELA CELLS; HUMAN PAPILLOMAVIRUS 18; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; SEQUENCE ANALYSIS, DNA; TRANSCRIPTIONAL ACTIVATION; UTERINE CERVICAL NEOPLASMS;

EID: 84881401766     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature12064     Document Type: Article

References (44)

1. Gey, G. O., Coffman, W. D.& Kubicek, M. T. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res. 12, 264-265 (1952).
2. Gartler, S. M. Apparent Hela cell contamination of human heteroploid cell lines. Nature 217, 750-751 (1968).
3. Skloot, R. The Immortal Life of Henrietta Lacks. (Crown Publishers, 2010).
4. Macville, M. et al. Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping. Cancer Res. 59, 141-150 (1999).
5. Kitzman, J. O. et al. Haplotype-resolved genome sequencing of a Gujarati Indian individual. Nature Biotechnol. 29, 59-63 (2011).
6. Nagaraj, N. et al. Deep proteome and transcriptome mapping of a human cancer cell line. Mol. Syst. Biol. 7, 548 (2011).
7. Dunham, I. et al. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012).
8. Meyer, M. et al. A high-coverage genome sequence from an archaic Denisovan individual. Science 338, 222-226 (2012).
9. The 1000 Genomes Project Consortium. An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56-65 (2012).
10. Exome Variant Server. http://evs.gs.washington.edu/EVS/(NHLBI GO Exome Sequencing Project (ESP), January 2012).
11. Morin, R. et al. Profiling the HeLa S3 transcriptome using randomly primed cDNA and massively parallel short-read sequencing. Biotechniques 45, 81-94 (2008).
12. The Cancer Genome Project. http://www.sanger.ac.uk/genetics/CGP/(Wellcome Trust Sanger Institute, January 2013).
13. Goodwin, E. C. et al. Rapid induction of senescence in human cervical carcinoma cells. Proc. Natl Acad. Sci. USA 97, 10978-10983 (2000).
14. Rosty, C. et al. Clinical and biological characteristics of cervical neoplasias with FGFR3 mutation. Mol. Cancer 4, 15 (2005).
15. Talora, C., Sgroi, D. C., Crum, C. P. & Dotto, G. P. Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expressionand late steps ofmalignant transformation. GenesDev. 16, 2252-2263 (2002).
16. White, E. A. et al. Comprehensive analysis of host cellular interactions with human papillomavirus E6 proteins identifies new E6 binding partners and reflects viral diversity. J. Virol. 86, 13174-13186 (2012).
17. Corver, W. E. et al. Genome-wide allelic state analysis on flow-sorted tumor fractions provides an accurate measure of chromosomal aberrations. Cancer Res. 68, 10333-10340 (2008).
18. Wingo, S. N. et al. Somatic LKB1 mutations promote cervical cancer progression. PLoS ONE 4, e5137 (2009).
19. Wistuba, I. I. et al. Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma. Cancer Res. 57, 3154-3158 (1997).
20. Nik-Zainal, S. et al. The life history of 21 breast cancers. Cell 149, 994-1007 (2012).
21. Fan, H. C., Wang, J., Potanina, A. & Quake, S. R. Whole-genome molecular haplotyping of single cells. Nature Biotechnol. 29, 51-57 (2011).
22. The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature 489, 519-525 (2012);
23. corrigendum 491, 288 (2012).
24. Puck, T. T. & Marcus, P. I. A rapid method for viable cell titration and clone production with HeLa cells in tissue culture: the use of X-irradiated cells to supply conditioning factors. Proc. Natl Acad. Sci. USA 41, 432-437 (1955).
25. Nelson-Rees, W. A., Daniels, D. W. & Flandermeyer, R. R. Cross-contamination of cells in culture. Science 212, 446-452 (1981).
26. Wentzensen, N., Vinokurova, S. & von Knebel Doeberitz, M. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res. 64, 3878-3884 (2004).
27. Lazo, P. A., DiPaolo, J. A. & Popescu, N. C. Amplification of the integrated viral transforming genes of human papillomavirus 18 and its 59-flanking cellular sequence located near the myc protooncogene in HeLa cells. Cancer Res. 49, 4305-4310 (1989).
28. Bouallaga, I.,Massicard, S.,Yaniv, M.& Thierry, F. Anenhanceosomecontaining the Jun B/Fra-2 heterodimer and the HMG-I(Y) architectural protein controls HPV 18 transcription. EMBO Rep. 1, 422-427 (2000).
29. Li, G. et al. Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation. Cell 148, 84-98 (2012).
30. Peter, M. et al. MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors. Oncogene 25, 5985-5993 (2006).
31. Ahmadiyeh, N. et al. 8q24 prostate, breast, and colon cancer risk loci show tissuespecific long-range interaction with MYC. Proc. Natl Acad. Sci. USA 107, 9742-9746 (2010).
32. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009).
33. McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297-1303 (2010).
34. Li, H. A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data. Bioinformatics 27, 2987-2993 (2011).
35. Gymrek, M., Golan, D., Rosset, S. & Erlich, Y. lobSTR: a short tandemrepeat profiler for personal genomes. Genome Res. 22, 1154-1162 (2012).
36. Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large genelists usingDAVIDbioinformatics resources.Nature Protocols 4,44-57 (2009).
37. Hach, F. et al. mrsFAST: a cache-oblivious algorithm for short-read mapping. Nature Methods 7, 576-577 (2010).
38. Sudmant, P. H. et al. Diversity of human copy number variation and multicopy genes. Science 330, 641-646 (2010).
39. Gnerre, S. et al. High-quality draft assemblies of mammalian genomes from massively parallel sequence data. Proc. Natl Acad. Sci. USA 108, 1513-1518 (2011).
40. Talkowski, M. E. et al. Next-generation sequencing strategies enable routine detection of balanced chromosome rearrangements for clinical diagnostics and genetic research. Am. J. Hum. Genet. 88, 469-481 (2011).
41. Adey, A. et al. Rapid, low-input, low-bias construction of shotgun fragment libraries by high-density in vitro transposition. Genome. Biol. 11, R119 (2010).
42. Duitama, J. et al. Fosmid-based whole genome haplotyping of a HapMap trio child: evaluation of single individual haplotyping techniques. Nucleic Acids Res. 40, 2041-2053 (2012).
43. Trapnell, C., Pachter, L. & Salzberg, S. L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105-1111 (2009).
44. Roberts, A., Pimentel, H., Trapnell, C.& Pachter, L. Identification of novel transcripts in annotated genomes using RNA-Seq. Bioinformatics 27, 2325-2329 (2011).